Company record
QuVa Pharma, Inc.
1 FDA warning letter since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about QuVa Pharma, Inc..
Warning letters
-
DrugsQuVa Pharma, Inc.
Compounding Pharmacy/Adulterated Drug Products
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jul 15 | Class II | QuVa Pharma, Inc. Drug |
Methohexital Sodium, 100 mg/10 mL (10 mg/mL), Total Volume: 10 mL, Rx only, Compounded drug, QuVa Pharma, 1075 W Park One Dr, Suite 100, Sugar Land, TX 77478, Product code: 70092-1310-46. Failed Impurities/Degradation Specifications |